Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways

Hanna Karvonen1,2, Harlan Barker1, Laura Kaleva1,2

  • 1Faculty of Medicine and Health Technology, Tampere University, 33014 Tampere, Finland.

Cells
|August 7, 2019
PubMed

Insights

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) signaling drives cancer stemness and metastasis. Targeting the Wnt5a-ROR1 pathway may overcome drug resistance in ROR1-positive cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is implicated in cancer stem cell (CSC) and epithelial-mesenchymal transition (EMT) phenotypes.
  • Aberrant ROR1 expression correlates with advanced disease, metastasis, and chemoresistance.
  • Wnt5a binding to ROR1 activates oncogenic pathways, including RhoA/Rac1 and PI3K/AKT.

Purpose of the Study:

  • To review the crosstalk between Wnt5a-ROR1 signaling and YAP/TAZ or BMI-1 networks in cancer.
  • To discuss current targeted strategies for ROR1-positive cancers.

Main Methods:

  • Literature review of studies on ROR1, Wnt5a, YAP/TAZ, BMI-1, CSCs, EMT, and targeted therapies.
  • Analysis of signaling pathways involved in ROR1-mediated oncogenesis.

Main Results:

  • Wnt5a-ROR1 signaling activates RhoA/Rac1 and PI3K/AKT pathways.
  • These pathways can lead to the upregulation of YAP/TAZ or BMI-1, promoting stemness and metastasis.
  • A feedback loop exists between Wnt5a-ROR1 and YAP/TAZ or BMI-1 signaling in cancer development.

Conclusions:

  • The Wnt5a-ROR1 pathway, in conjunction with YAP/TAZ or BMI-1, plays a critical role in cancer progression and treatment resistance.
  • Targeting ROR1 offers a promising therapeutic strategy for ROR1-positive cancers.

Related Concept Videos

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.9K
SN1 Reaction: Mechanism02:25

SN1 Reaction: Mechanism

Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism. 
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
14.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism01:26

Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism

The Hofmann and Curtius rearrangement reactions can be applied to synthesize primary amines from carboxylic acid derivatives such as amides and acyl azides. In the Hofmann rearrangement, a primary amide undergoes deprotonation in the presence of a base, followed by halogenation to generate an N-haloamide. A second proton abstraction produces a stabilized anionic species, which rearranges to an isocyanate intermediate via an alkyl group migration from the carbonyl carbon to the neighboring...
4.0K